2014 Minnesota Statutes

CHAPTER 151. PHARMACY

Table of Sections

Section	Headnote
BOARD OF PHARMACY
151.01	DEFINITIONS.
151.02	STATE BOARD OF PHARMACY.
151.03	MEMBERSHIP.
151.04	RECOMMENDED NAMES.
151.05	ELECTION OF OFFICERS.
151.06	POWERS AND DUTIES.
151.061	UNFAIR PRICE DISCRIMINATION.
151.065	FEE AMOUNTS.
151.07	MEETINGS; EXAMINATION FEE.
151.071	DISCIPLINARY ACTION.
151.072	REPORTING OBLIGATIONS.
151.073	IMMUNITY.
151.074	LICENSEE OR REGISTRANT COOPERATION.
151.075	DISCIPLINARY RECORD ON JUDICIAL REVIEW.
151.08	[Repealed, 1975 c 136 s 77]
151.09	[Repealed, 1976 c 222 s 209]
151.095	INACTIVE STATUS LICENSE.
151.10	QUALIFICATIONS OF APPLICANTS.
151.101	INTERNSHIP.
151.102	PHARMACY TECHNICIAN.
151.11	[Repealed, 1988 c 550 s 20]
151.12	RECIPROCITY; LICENSURE.
151.13	RENEWAL FEE; CONTINUING EDUCATION.
151.14	REINSTATEMENTS.
151.15	COMPOUNDING DRUGS UNLAWFUL UNDER CERTAIN CONDITIONS.
151.16	VIOLATION A GROSS MISDEMEANOR.
151.17	UNLAWFUL USE OF "PHARMACIST."
151.18	UNLAWFUL TO USE MISLEADING NAME.
151.19	REGISTRATION; FEES.
151.20	[Repealed, 1969 c 933 s 22]
151.21	SUBSTITUTION.
151.211	RECORDS OF PRESCRIPTIONS.
151.212	LABEL OF PRESCRIPTION DRUG CONTAINERS.
151.213	COPIES OF PRESCRIPTIONS.
151.214	PAYMENT DISCLOSURE.
151.215	CERTIFICATION.
151.22	LIABILITY FOR QUALITY OF DRUGS.
151.23	POISONS MUST BE LABELED.
151.24	SALE OF POISONS MUST BE RECORDED.
151.25	[Repealed, 2013 c 108 art 10 s 13]
151.252	LICENSING OF DRUG MANUFACTURERS; FEES; PROHIBITIONS.
151.253	COMPOUNDING.
151.26	EXCEPTIONS.
151.27	EXPENSES.
151.28	[Repealed, 1988 c 550 s 20]
151.29	VIOLATION A MISDEMEANOR.
151.30	COUNTY ATTORNEY TO PROSECUTE.
151.301	REPORTS TO COMMISSIONER OF HEALTH.
151.302	IMMUNITY.
151.31	[Repealed, 1988 c 550 s 20]
PHARMACY PRACTICE ACT OF 1988
151.32	CITATION.
151.33	CARELESS DISTRIBUTION OF DRUGS.
151.34	PROHIBITED ACTS.
151.35	DRUGS, ADULTERATION.
151.36	DRUGS, MISBRANDING.
151.361	MANUFACTURER DISCLOSURE.
151.37	LEGEND DRUGS, WHO MAY PRESCRIBE, POSSESS.
151.38	EMBARGOES.
151.39	DISTRESSED DRUGS.
151.40	POSSESSION AND SALE OF HYPODERMIC SYRINGES AND NEEDLES.
151.41	[Repealed, 1981 c 323 s 4; 1983 c 312 art 1 s 27]
LONG-TERM CARE RESIDENT ACCESS TO PHARMACEUTICALS ACT
151.415	LONG-TERM CARE RESIDENT ACCESS TO PHARMACEUTICALS ACT.
WHOLESALE DRUG DISTRIBUTION LICENSING ACT
151.42	CITATION.
151.43	SCOPE.
151.44	DEFINITIONS.
151.45	[Repealed, 2013 c 108 art 10 s 13]
151.46	PROHIBITED DRUG PURCHASES OR RECEIPT.
151.461	GIFTS TO PRACTITIONERS PROHIBITED.
151.47	WHOLESALE DRUG DISTRIBUTOR LICENSING REQUIREMENTS.
151.48	[Repealed, 2013 c 108 art 10 s 13]
151.49	LICENSE RENEWAL APPLICATION PROCEDURES.
151.50	RULES.
151.51	BOARD ACCESS TO WHOLESALE DRUG DISTRIBUTOR RECORDS.
CANCER DRUG REPOSITORY PROGRAM
151.55	CANCER DRUG REPOSITORY PROGRAM.
RETURN OF UNUSED DRUGS
151.56	COUNTY RETURN OF UNUSED DRUGS OR MEDICAL DEVICES.
AUTOMATED DRUG DISTRIBUTION
151.58	AUTOMATED DRUG DISTRIBUTION SYSTEMS.
PHARMACY AUDIT INTEGRITY PROGRAM
151.60	PHARMACY AUDIT INTEGRITY PROGRAM.
151.61	DEFINITIONS.
151.62	PHARMACY BENEFIT MANAGER CONTRACT.
151.63	PROCEDURE AND PROCESS FOR CONDUCTING AND REPORTING AN AUDIT.
151.64	REQUIREMENTS FOR RECOUPMENT OR CHARGEBACK.
151.65	DOCUMENTATION.
151.66	APPEALS PROCESS.
151.67	AUDIT INFORMATION AND REPORTS.
151.68	DISCLOSURES TO PLAN SPONSOR.
151.69	APPLICABILITY OF OTHER LAWS AND REGULATIONS.
151.70	VIOLATIONS.
MAXIMUM ALLOWABLE COST PRICING
151.71	MAXIMUM ALLOWABLE COST PRICING.